-
Founded in:
2001-09-25 -
Country:
China -
Address:
Guannan Industrial Park, Wuhan East Lake New Technology Development Zone -
Tax NO.:
914201007310641045 -
Registered Funds:
26 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Clotrimazole |
1. Inhibit plasminogen activators, so that plasminogen cannot be activated into plasmin, thereby inhibiting the dissolution of fibrin and producing a hemostatic effect; 2. Promote the release of active substances by platelets, enhance platelet aggregation and adhesion, shorten coagulation time, and produce a hemostatic effect; 3. Enhance capillary resistance, reduce capillary permeability, and thus reduce bleeding.
More
1. Inhibit plasminogen activators, so that plasminogen cannot be activated into plasmin, thereby inhibiting the dissolution of fibrin and producing a hemostatic effect; 2. Promote the release of active substances by platelets, enhance platelet aggregation and adhesion, shorten coagulation time, and produce a hemostatic effect; 3. Enhance capillary resistance, reduce capillary permeability, and thus reduce bleeding. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Calcium folinatc |
This product is a formyl derivative of tetrahydrofolate, mainly used for the rescue of high-dose methotrexate and other folic acid antagonists. It limits the degree of damage to normal cells by methotrexate and can reverse the reaction of methotrexate to the bone marrow and gastrointestinal mucosa, but has no significant effect on the neurotoxicity caused by methotrexate that has already occurred.
More
This product is a formyl derivative of tetrahydrofolate, mainly used for the rescue of high-dose methotrexate and other folic acid antagonists. It limits the degree of damage to normal cells by methotrexate and can reverse the reaction of methotrexate to the bone marrow and gastrointestinal mucosa, but has no significant effect on the neurotoxicity caused by methotrexate that has already occurred. |
6035-45-6 | 6 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Clotrimazole |
(1) Inhibit plasminogen activators, preventing plasminogen from activating into plasmin, thereby inhibiting the dissolution of fibrin and producing a hemostatic effect. (2) Promote the release of active substances from platelets, enhance platelet aggregation and adhesion, shorten coagulation time, and produce a hemostatic effect. (3) Enhance capillary resistance and reduce capillary permeability, thereby reducing bleeding.
More
(1) Inhibit plasminogen activators, preventing plasminogen from activating into plasmin, thereby inhibiting the dissolution of fibrin and producing a hemostatic effect. (2) Promote the release of active substances from platelets, enhance platelet aggregation and adhesion, shorten coagulation time, and produce a hemostatic effect. (3) Enhance capillary resistance and reduce capillary permeability, thereby reducing bleeding. |
0 |